Compare WSR & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WSR | CTKB |
|---|---|---|
| Founded | 1998 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 709.2M | 652.1M |
| IPO Year | 2010 | 2021 |
| Metric | WSR | CTKB |
|---|---|---|
| Price | $14.92 | $4.51 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 5 |
| Target Price | ★ $16.00 | $5.70 |
| AVG Volume (30 Days) | 186.9K | ★ 836.1K |
| Earning Date | 02-25-2026 | 02-26-2026 |
| Dividend Yield | ★ 3.81% | N/A |
| EPS Growth | ★ 108.75 | N/A |
| EPS | ★ 0.86 | N/A |
| Revenue | $157,788,000.00 | ★ $196,828,000.00 |
| Revenue This Year | $3.30 | $0.15 |
| Revenue Next Year | $6.19 | $5.15 |
| P/E Ratio | $17.45 | ★ N/A |
| Revenue Growth | ★ 5.59 | N/A |
| 52 Week Low | $11.43 | $2.37 |
| 52 Week High | $14.99 | $6.18 |
| Indicator | WSR | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 71.47 | 31.91 |
| Support Level | $13.88 | $4.86 |
| Resistance Level | $14.37 | $5.29 |
| Average True Range (ATR) | 0.28 | 0.25 |
| MACD | 0.05 | -0.09 |
| Stochastic Oscillator | 93.21 | 5.16 |
Whitestone REIT is a real estate investment trust (REIT) engaged in owning and operating commercial properties in culturally diverse markets in metropolitan areas. The company's primary business objective is to increase shareholder value by acquiring, owning, and operating Community Centered Properties. Its property portfolio includes retail and mixed-use properties located in business friendly locations in and around Austin, Chicago, Dallas-Fort Worth, Houston, Phoenix, and San Antonio. The properties are convenience-focused: merchandised with a mix of service-oriented tenants providing food (restaurants and grocers), self-care (health and fitness), services (financial and logistics), education, and entertainment to the surrounding communities.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.